Maarten Kraan

Company: AM-Pharma

Job title: Chief Medical Officer

Seminars:

Navigating Phase 3 Clinical Trials for Sepsis-Associated Acute Kidney Injury to Break the Mould in AKI 2:30 pm

From identifying patients to defining endpoints: analyzing a 650-patient phase 3 trial in AKI Surmounting 28-day mortality data and composite endpoints Redefining a new path to approval: what does the future of AKI drug development look like?Read more

day: Seminar Day